Cancer Research
Triple Immune Checkpoint Blockade Tested in Advanced Solid Tumors
A Phase 1/2 trial explores combining KIR, PD-1, and CTLA-4 inhibitors to unlock stronger anti-tumor immunity.
Ensaio Clínico
20 de mai. de 2026 0
Tema
Câncer
Latest breakthroughs in cancer research, treatment, and prevention
606 artigos
Cancer Research
NCI Study Tests MRI and PET Scanning for Early Breast Cancer Detection in BRCA Carriers
A completed NCI trial evaluated advanced imaging and breast duct lavage in women with BRCA1/BRCA2 mutations to improve early cancer detection.
Ensaio Clínico
20 de mai. de 2026 0
Cancer Research
Tumors Evolve Hidden Escape Routes That Dodge Immune Attack in Lung Cancer
New research reveals how lung cancer subclones develop distinct immune evasion strategies, complicating immunotherapy response.
Artigo Científico
20 de mai. de 2026 0
Cancer Research
MSK Research Drives 11 FDA Cancer Drug Approvals in 2025
Memorial Sloan Kettering-led trials produced 11 new FDA-approved cancer therapies in a single year, spanning multiple tumor types.
Aprovação de Medicamento
19 de mai. de 2026 0
Cancer Research
Why Cushing's Tumors Stop Responding to Temozolomide
New research reveals how corticotroph pituitary tumors develop resistance to temozolomide through clonal selection of high MGMT-expressing cells.
Artigo Científico
19 de mai. de 2026 0
Cancer Research
Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet
A multinational study of 4,913 patients finds EBRT delivers survival outcomes comparable to surgery and ablation for early hepatocellular carcinoma.
Artigo Científico
19 de mai. de 2026 0
Cancer Research
Radiation to Metastases Cuts Cancer Progression Risk in Half in Phase II Trial
Adding targeted radiation to standard therapy reduced progression by 46% across multiple cancer types in the EXTEND trial.
Artigo Científico
19 de mai. de 2026 0
Cancer Research
Chemo-Free HER2+ Breast Cancer Treatment Achieves Excellent 5-Year Survival
A randomized trial shows hormone receptor-positive/HER2+ early breast cancer patients had 100% 5-year overall survival with endocrine therapy plus dual HER2 blockade.
Artigo Científico
19 de mai. de 2026 0
Cancer Research
New Macrocyclic Peptides Selectively Kill Chemotherapy-Resistant Lung Cancer Cells
Orally bioavailable cyclin A/B RxL inhibitors exploit a cell-cycle vulnerability in small-cell lung cancer and other G1-S-checkpoint-deficient tumors.
Artigo Científico
18 de mai. de 2026 0
Cancer Research
Cancer's Growth Protein MYC Found to Secretly Repair Chemo-Damaged DNA
MYC protein doesn't just fuel tumor growth — it also repairs DNA damage from chemotherapy, revealing a key resistance mechanism.
Comunicado de Imprensa
17 de mai. de 2026 0
Cancer Research
Phase I Trial Tests Ipilimumab Added to Chemoradiation for Advanced Cervical Cancer
NCI-sponsored trial evaluates safety and optimal dosing of immune checkpoint blockade following standard chemoradiation in locally advanced cervical cancer.
Ensaio Clínico
17 de mai. de 2026 0
Cancer Research
Dual Checkpoint Blockade Plus FOLFOX Chemo Tested in Metastatic Colorectal Cancer
A Phase 1/2 trial tests whether combining durvalumab, tremelimumab, and FOLFOX chemotherapy can safely boost immune response in mCRC.
Ensaio Clínico
17 de mai. de 2026 0